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Abstract
To evaluate the passage of cytokines through the gastrointestinal tract, we investigated the digestion of interleukin-8 (IL-8) and
tumour necrosis factor a (TNFa), in vitro and in vivo, and their propensity to induce intestinal inflammation. We serially
immuno-assayed IL-8 and TNFa solutions co-incubated with each of three pancreatin preparations at pH 4.5 and pH 8. We
gavaged IL-8, TNFa and marker into 15 Wistar rats, and measured their faecal cytokine concentrations by ELISA and
histologically examined their guts. IL-8 immunoreactivity was extinguished by all pancreatin preparations after 1 h of incubation
at 37 8C. TNFa concentration progressively fell from 1 to 4 h with all enzyme preparations. Buffer control samples maintained
their cytokine concentrations throughout incubation. No IL-8 or TNFa was detected in any rat faecal pellets. There was no
significant proinflammatory effect of the gavaged cytokines on rat intestine. IL-8 and TNFa in aqueous solution could well be
fully digested in the CF gut when transit time is normal and exogenous enzymes are provided, although cytokines swallowed in
viscous sputum may be protected from such digestion.  2002 European Cystic Fibrosis Society. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Tentative reports of raised faecal cytokine concentra-
tions have been made following speculativly assayed
faecal samples, which used ELISAs validated for use in
non-faecal samples w1,2x. Similarly, we w3x and others
w4x have reported raised faecally derived cytokine con-
centrations in patients with cystic fibrosis. In our latter
study we suggested that they originated from swallowed
sputum, because there seemed to be a relationship
between chest disease severity and faecal IL-8 concen-
tration. This stimulated us to speculate that a repeatable
non-invasive proxy measure of pulmonary inflammatory
severity might be developed. The validity of the ELISA
assays for faecally derived IL-8 and TNFa used in these
early studies was brought into question, when we found
that they paradoxically measure increasing cytokine
concentrations with dilution of faecal extract w5x. Thus,
the presence of lumenal cytokine immunoreactivity may
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be a result of intestinal inflammation, swallowed sputum
or artefact.
We were therefore interested to ascertain whether
pancreatic enzyme preparations commonly used in cystic
fibrosis can digest sputum-derived cytokines in condi-
tions likely to be encountered in the CF gut, and whether
IL-8 and TNFa can pass through the gut of a pancreatic
sufficient mammal in an assayable form, and mediate
intestinal inflammation in doses that a CF patient would
be expected to swallow.
We chose to gavage the cytokines into the pancreatic
sufficient Wistar rat because these rats respond to human
recombinant IL-8 w6–9x and TNFa7 w10x with responses
that parallel the human response to these cytokines, but
the rat IL-8 equivalent chemokine GROyCINC is immu-
nologically distinct from human IL-8 w11x. This allowed
us to be confident that any faecal IL-8 detected in rat
faeces originated from the administered human cytokine.
2. Methods
2.1. Enzymatic degradation of interleukin-8 and TNFa
Enzyme solutions of Creon Forte (Solvay), Pancrease
(Cilag) and CotazymS (Organon) were prepared to an
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Fig. 1. IL-8 and enzyme coincubation experiment.
estimated concentration of 250 units of lipase activity
per ml in both pH 4.5 and pH 8 Tris buffer, and aliquots
of these solutions were analysed for tryptic activity.
A 1-ml aliquot of IL-8 (2000 pgyml) or TNFa (4545
pgyml) was added to 1 ml of each enzyme solution and
control buffer and incubated at 37 8C in a water bath.
After 1 h a 500-ml aliquot was removed and the enzyme
activity was inhibited by the addition of 50 ml of soy
bean trypsin inhibitor (SBTI; 1 mgyml in phosphate-
buffered saline), 28 ml of 0.3 M EDTA and 12 ml of
phenylmethylsulfonlylfluoride (PMSF; in 95% alcohol),
followed by 30 ml of newborn calf serum 2 min later.
Samples were immediately frozen at y70 8C. After 4 h
of incubation the remaining 1500 ml was similarly
treated and frozen in 500-ml aliquots.
Without any cytokine digestion, this sample dilution
would lead to concentrations of cytokine of 806.45 pgy
ml IL-8 and 1832.84 pgyml TNFa. To test the cytokine
recovery of the assay in this environment, triplicate
samples from digestion of IL-8 had an IL-8 spike added
to increase the IL-8 concentration by 1000 pgyml before
reassay (Fig. 1).
2.2. Sputum
In order to assess the influence of sputum on enzy-
matic digestion of cytokines, fresh sputum from a boy
with end-stage CF lung disease was homogenised in
buffer (1 gyml) and assayed for IL-8 concentration
following incubation with Creon Forte and with control
buffer.
2.3. Cytokine transit through the Wistar rat gut
A total of 15 male Wistar rats (200 g) were divided
into three groups of five rats. All 15 rats were given a
1-ml gavage of either phosphate-buffered saline (PBS),
interleukin-8 (3000 pg) in PBS or interleukin-8 (3000
pg) and TNFa (200 pg) in PBS. These were weight-
for-weight dosages equivalent to a 60-kg patient swal-
lowing 30 g of sputum containing typical amounts of
IL-8 w12x and TNFa w13x. The rats were caged above
wire mesh and stool collection commenced. They were
given a 1-ml gavage of Indian ink (Pelikan) 6 h later,
and stool collection continued at 6-h intervals until
faecal pellets became black. Faecal pellets containing
ink were not included in the collection for homogeni-
sation. Faecal samples were immediately frozen at y20
8C. Frozen faecal samples were powdered using a mortar
and pestle, homogenised in five times their weight of
phosphate-buffered saline and centrifuged at 20 000=g
for 15 min. Supernatant was frozen at y70 8C and
subsequently analysed for IL-8 and TNF concentrations,
using a protocol previously validated for use of the
Quantikine kits with human samples w5x.
2.4. Faecal supernatant cytokine assays
All faecally derived samples were prediluted 1:1 in
newborn calf serum, and any further dilution was made
using calf serum as the diluent. Cytokine assays were
performed using TNFa and IL-8 Quantikine kits (R&D
Systems Europe, Abingdon) according to the manufac-
turer’s instructions for cell culture samples.
To confirm assay linearity for the faecally derived
samples, an additional four-fold dilution in newborn calf
serum was analysed for each sample. The assay was
accepted as being linear for each sample if the cytokine
concentration calculated from each dilution was within
10% of the mean result for both dilutions; accordingly,
this mean aliquot cytokine concentration was used to
calculate the faecal cytokine concentration. With this
protocol in the IL-8 assay, using human faecal superna-
tants, the intra-assay coefficient of variation was 3.46%
(ns7), the inter-assay coefficient of variation was
6.85% (ns5) and mean (S.D.) spike recovery was
92.12% (12.48%) (ns8). For the TNFa assay these
figures were 4.57% (ns10), 6.92% (ns2) and 91.48%
(5.57%) (ns8), respectively.
Duplicates of supernatants from faeces of four of the
five rats dosed with only phosphate-buffered saline were
spiked with IL-8 to 500 pgyml to check that the human
faeces assay protocol was valid in Wistar rat faeces.
2.5. Histology
When faecal specimen collection was complete, the
rats were euthanased with a lethal (1–3 ml) intra-
peritoneal dose of phenobarbitone sodium (325 mgyml;
Lethobarb,Virbac, Sydney, NSW). Their gastrointestinal
tracts were dissected and representative samples of
stomach, duodenum, ileum and colon were taken and
processed for histological examination. These were
examined blind for the presence of intestinal
inflammation.
Blinding was achieved in the histology processing
laboratory by technical staff who played no part in
examination of the histology. Cassettes containing the
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Table 1
TNFa concentrations following in vitro digestion
Preparation Tryptic TNFa concentration (pgyml)a
activity
pH 8 pH 4.5
(kUyl)
1 h 4 h 1 h 4 h
Creon Forte 4.3 1066.20 132.82 )2000 986.36
1027.67 124.14 )2000 1000.54
955.16 125.67 )2000 1024.05
Pancrease 17.7 797.61 118.56 31.59 7.38b
933.60 115.26 29.93 5.12b
929.73 128.72 35.00 8.31b
Cotazym S 15.1 943.71 117.29 197.67 16.22
908.74 140.43 35.00 12.77b
961.80 136.61 39.56 13.64b
Buffer -0.05 3470.90 3822.90 5614.91 5244.66
2711.32 3542.54 5405.56 4807.61
2659.56 3592.49 5779.02 5779.02
Expected concentration 1833 pgyml.a
Calculated by interpolation.b
rat tissue were labelled with the rat serial number and
the site of origin of the tissue. Haematoxylin- and eosin-
stained slides were labelled with a random serial number.
The randomisation key was recorded on a log sheet and
placed in a sealed envelope. This was not opened until
after the slides had been examined.
All tissue on each slide was examined at 400=
magnification for the presence of neutrophil polymorphs.
Segmented polymorphs that did not have demonstrably
eosinophilic granules were classified as neutrophils. In
order to identify all possible foci of acute inflammation,
all tissue neutrophils observed were recorded. A focus
of inflammation was defined as ‘at least three neutro-
phils in one high-power (400=) field.’
2.6. Statistical methods
Analysis of variance and paired t-tests were used to
test differences between groups where appropriate.
2.7. Ethical approval
The study was approved by the University of Queens-
land animal experimentation ethics committee and the
ethics committee of The Royal Children’s Hospital,
Brisbane.
3. Results
3.1. Enzymatic cytokine digestion in vitro
3.1.1. Interleukin-8 assay
No IL-8 immunoreactivity was detected in any of the
triplicate tubes loaded with both enzyme and cytokine,
at incubation of either 4 or 1 h, at either pH 8 or pH
4.5. Mean IL-8 concentrations in the buffer samples
were: 603 pgyml at 1 h and 853 pgyml at 4 h, an
apparent rise (ts6.05, Ps0.004), at pH 8.0; and 587
pgyml at 1 h and 514 pgyml at 4 h, no significant
change (ts2.31, Ps0.08), at pH 4.5.
3.1.2. Spiked IL-8 digestion samples
The mean IL-8 concentration for the nine samples
from the IL-8 digestion at pH 8 that were subsequently
spiked to 1000 pgyml, using the assay 2000 pgyml IL-
8 standard as spiking solution, was 858.77 pgyml. Mean
IL-8 concentrations were 873.68, 864.54 and 838.09
pgyml for Creon Forte, Pancrease and Cotazym co-
incubated and spiked samples, respectively.
3.2. TNFa assay results
TNFa was measurable in all TNFa samples subjected
to digestion at pH 4.5 and pH 8.0, with a progressive
reduction in TNFa concentration between 1 and 4 h of
enzyme co-incubation, whilst the control samples with-
out enzyme maintained their high cytokine concentra-
tions. Samples that were not inoculated with cytokine
had no TNFa immunoreactivity. Results are shown in
Table 1.
3.3. Sputum sample
Interleukin-8 recovered from the CF sputum incubated
with buffer was 130 150 pgyg, whilst 34 680 pgyg was
recovered from the sample incubated with Creon Forte
at pH 8.0. Neither the digested nor the undigested
sputum samples contained assayable concentrations of
TNFa.
3.4. Cytokine transit through the Wistar rat gut
Mean stool weight collected was 2.67 g for rats dosed
with PBS alone, 2.53 g for rats dosed with 3000 pg IL-
8 in PBS, and 2.98 g for rats dosed with 3000 pg IL-8
and 200 pg TNFa in PBS. These stool weights were
not significantly different (Fs1.51, Ps0.26 by
ANOVA).
No TNFa immunoreactivity was detected in the faecal
samples of the five rats that were given TNFa and IL-
8, nor in the five control rats that received phosphate-
buffered saline.
No significant IL-8 immunoreactivity was detected in
any experimental or control rats. Of the four faecal
samples that were spiked to 500 pgyml, all had assayable
quantities of IL-8 (Table 2), with a mean IL-8 concen-
tration was 773 pgyml. Table 2 also shows the percent-
age variation in the cytokine concentration determined
from two dilutions of the same sample. These show that
the assay was linear for these samples.
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Of the four sampling sites for the 15 rats, a single
slide demonstrated a focus of inflammation. This
occurred in stomach tissue just distal to the gastro-
oesophageal junction, in a rat who had been dosed with
3000 pg of IL-8. This rat also had two isolated neutro-
phils in the distal small bowel, and two isolated neutro-
phils in the colon. Two other rats dosed with IL-8 alone
had tissue neutrophils identified, one with three isolated
neutrophils in the colon and the other with a single
neutrophil in the proximal small bowel.
A single neutrophil was observed in the colon of one
rat dosed with only phosphate-buffered saline. Four of
five rats dosed with both IL-8 and TNFa were noted to
have solitary tissue neutrophils, but no focus of inflam-
mation. One of these rats had solitary neutrophils in
stomach, distal small bowel and colon, one in distal
small bowel and colon, and one rat each in proximal
and distal small bowel.
4. Discussion
With in vitro digestion, the presence of assayable
quantities of TNFa in the samples for all three enzyme
preparations at both time points allows us to conclude
that there had been a progressive decrease in TNFa
concentration with time in these samples. That this
decrease was smallest in the preparation with the lowest
tryptic activity measured suggests that enzymatic activity
is responsible for the decrease. It might be argued that
the failure to detect IL-8 in the digestion experiment
was the result of enzymatic interference with the assay
rather than cytokine digestion, but the subsequent recov-
ery of an average 85% of an IL-8 spike after the
addition of protease inhibitors makes this unlikely. We
are led to conclude that both IL-8 and TNFa are
efficiently digested by all three tested pancreatic enzyme
preparations both at pH 4.5 and pH 8. The four-fold
reduction in sputum IL-8 concentration measured on
incubation with Creon Forte under circumstances that
abolished IL-8 immunoreactivity in aqueous samples
suggests that sputum may provide a degree of protection
for the chemokine against pancreatic enzymes.
Two technical points in these assays deserve com-
ment. Firstly, we have observed a significant reduction
in IL-8 recovery in buffer incubation at 1 h and not at
4 h, and secondly, the concentrations of TNFa calculated
following buffer incubation at both pH 4.5 and pH 8
show concentrations of over two-fold the concentration
administered. We suspect that these perturbations are
due to the sensitivity of the ELISA assays to minor
changes in the chemical composition of the assay wells.
This would be in accord with the non-linear assay
characteristics demonstrated in our previous work on
unvalidated assays in human faecal homogenate. Despite
these variations from ideal behaviour in the control
samples, the contrast with the changes observed in the
enzyme-incubated samples is marked, and there remains
convincing evidence of enzyme digestion in those wells.
In the rat-gut cytokine transit experiment, it was
necessary to have a significant interval between cytokine
and Indian ink administration so that the cytokines were
not adsorbed onto the carbon particles of the ink. The
cytokine dilution resulting from this interval exposed
the study to the risk that cytokine was diluted beyond
the detection limit of the assay. The maximum weight
of rat faecal pellets was 3.44 g. If all of the 3000 pg of
IL-8 and 200 pg of TNFa administered to the rat passed
through the gut, cytokine concentration in the aliquots
would be 145 pg IL-8yml and 9.6 pg TNFayml. These
concentrations of IL-8 and TNFa were 10- and two-
fold the assay detection limit, respectively. It is safe to
conclude that the Wistar rat destroys at least half of the
administered dose of TNFa and at least 90% of the
administered dose of IL-8 during passage through its
intestine. This is consistent with the efficient digestion
of these cytokines in the pancreatic sufficient mammal.
Whilst faecal pellets were collected at 6-h intervals and
would have been at room temperature for this time, we
have assumed that little cytokine digestion occurred
because of the dry nature of the pellets.
This efficient digestion is consistent with the lack of
an intestinal inflammatory response. The sole instance
of intestinal inflammation in one rat stomach, just distal
to the oesophago-gastric junction, could be a result of
the administration of IL-8 to the stomach. However, the
fact that only one rat was thus affected is more consistent
with inflammation having been caused by the process
of passing the gavage needle through the gastro-oeso-
phageal junction. This study was designed not to miss
a subtle acute inflammatory focus. The tissue neutrophils
observed were not sufficiently numerous to satisfy the
study criteria for a focus of inflammation, but they could
signify mild acute inflammation. All but one of the
slides containing isolated neutrophils were in rats that
were gavaged with a dose of IL-8, despite the blinding
of the histological assessor to the origin of the slides.
Because of the possibility of misclassifying the mor-
phology of an individual polymorph, we had required
three neutrophils per high-powered field to conclude
that a focus of inflammation was present. Whilst this
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criterion was arbitrary, it was set at the stage of study
design and should be adhered to. In making a post-hoc
assessment of these data, we should consider the pro-
portion of the rat gut that was examined. We estimate
that a total of 8 cm=5 mm of tissue was examined for
each rat, and that the length of each rat gut was in
excess of 40 cm. With this proportion of tissue exami-
nation, we do not believe that our data support the
existence of even the most subtle of inflammatory
responses to gavaged cytokine.
We conclude that the bulk of swallowed IL-8 and
TNFa is digested in pancreatic sufficient animals, and
that modern pancreatic enzyme replacement therapy is
also effective at digesting these cytokines, even at the
sub-optimal pH likely to be encountered in the CF small
intestine. Whilst cytokines in sputum are also subject to
digestion, they may enjoy a degree of protection from
digestion by the physical nature of the sputum. Any
such protection is likely to be influenced by any variant
gastric motor function in cystic fibrosis w14–16x, and
further work could explore these issues. Small amounts
of swallowed cytokine may gain access to the intestinal
lamina propria and remain physiologically active, but
we have not found sufficient evidence to suggest that
doses of cytokines swallowed by cystic fibrosis patients
could be measured as an index of pulmonary inflam-
mation, or act as a cause of intestinal inflammation.
Only if whole gut transit time were reduced to 1 or 2 h
would we expect to be able to assay any sputum-derived
cytokines in faeces, a situation that would occur in
whole-gut lavage studies. Faecal cytokines that we have
previously described w3x are unlikely to originate from
sputum and we believe that they are a result of artefact.
Cytokines in whole-gut lavage fluid may result from
pulmonary or intestinal inflammation or artefact. Smyth
et al. have recently ascribed the inflammatory markers
they detected in whole-gut lavage fluid to constitutional
intestinal inflammation in cystic fibrosis w4x; however,
their assay protocols were unvalidated and high IL-8
concentrations in their study may well be overestimates
of the true concentration w17x. This makes it likely that
they have been detecting IL-8 immunoreactivity result-
ing from the intestinal transit of pulmonary-derived
cytokines. Even if whole-gut lavage cytokine concentra-
tions could be measured reproducibly, the invasive
nature of whole-gut lavage in children would be an
obstacle to its use as a proxy measure of pulmonary
inflammatory activity.
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